Literature DB >> 12940929

Essential fatty acid status in paediatric Crohn's disease: relationship with disease activity and nutritional status.

T M Trebble1, S A Wootton, A May, M D S Erlewyn-Lajeunesse, A Chakraborty, M A Mullee, M A Stroud, R M Beattie.   

Abstract

BACKGROUND: Active paediatric Crohn's disease is associated with nutritional deficiencies and altered nutrient intake. The availability of essential fatty acids (linoleic and alpha-linolenic acids) or their derivatives (arachidonic and eicosapentaenoic acids) may alter in plasma and cell membrane phospholipid in protein-energy malnutrition in children and in Crohn's disease in adults. AIM: To investigate the relationship of fatty acid phospholipid profiles with disease activity and nutritional status in paediatric Crohn's disease.
METHODS: The fatty acid (proportionate) composition of plasma and erythrocyte phosphatidylcholine was determined in 30 patients (10.3-17.0 years) stratified into active and quiescent Crohn's disease (paediatric Crohn's disease activity index) and high and low body mass (body mass index centile).
RESULTS: In plasma phosphatidylcholine, active disease activity was associated with a lower level of alpha-linolenic acid compared with that in quiescent disease (P < 0.05). A body mass index below the 50th centile was associated with active Crohn's disease, low linoleic and alpha-linolenic acids and high arachidonic acid (P < 0.05) in plasma phosphatidylcholine, and low alpha-linolenic acid in erythrocyte phosphatidylcholine. These findings could not be explained through differences in habitual dietary fat intake.
CONCLUSION: In paediatric Crohn's disease, a low body mass index centile and high disease activity are associated with altered profiles of essential fatty acids and their derivatives, which may reflect altered metabolic demand.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12940929     DOI: 10.1046/j.1365-2036.2003.01707.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Cholesterol metabolism in active Crohn's disease.

Authors:  Vladimír Hrabovský; Zdenek Zadák; Vladimír Bláha; Radomír Hyspler; Tomás Karlík; Arnost Martínek; Alice Mendlová
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?

Authors:  Valérie Marcil; Emile Levy; Devendra Amre; Alain Bitton; Ana Maria Guilhon de Araújo Sant'Anna; Andrew Szilagy; Daniel Sinnett; Ernest G Seidman
Journal:  Inflamm Bowel Dis       Date:  2019-07-17       Impact factor: 5.325

3.  There Is a Differential Pattern in the Fatty Acid Profile in Children with CD Compared to Children with UC.

Authors:  Justyna Kikut; Arleta Drozd; Małgorzata Mokrzycka; Urszula Grzybowska-Chlebowczyk; Maciej Ziętek; Małgorzata Szczuko
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

4.  The assessment of plasma fatty acid profiles in newly diagnosed treatment-naive paediatric Crohn's disease.

Authors:  J Schwarz; M Vecka; F Stožický; R Pomahačová; B Staňková; E Tvrzická; M Kreslová; R Zahálková; J Sýkora
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

Review 5.  Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases.

Authors:  Lidiya V Boldyreva; Maryana V Morozova; Snezhanna S Saydakova; Elena N Kozhevnikova
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

6.  Cutaneous presentation of kwashiorkor due to infantile Crohn's disease.

Authors:  Luluah Al-Mubarak; Sultan Al-Khenaizan; Talal Al Goufi
Journal:  Eur J Pediatr       Date:  2009-04-08       Impact factor: 3.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.